S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
NYSE:CNMD

CONMED (CNMD) Stock Price, News & Analysis

$72.64
+1.56 (+2.19%)
(As of 04/19/2024 ET)
Today's Range
$71.15
$73.04
50-Day Range
$71.08
$87.76
52-Week Range
$70.57
$138.47
Volume
506,301 shs
Average Volume
431,319 shs
Market Capitalization
$2.24 billion
P/E Ratio
35.61
Dividend Yield
1.10%
Price Target
$120.43

CONMED MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.86 Rating Score
Upside/​Downside
65.8% Upside
$120.43 Price Target
Short Interest
Bearish
13.22% of Shares Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-0.74
Upright™ Environmental Score
News Sentiment
0.04mentions of CONMED in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
30.65%
From $4.34 to $5.67 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.79 out of 5 stars

Medical Sector

45th out of 907 stocks

Electromedical Equipment Industry

1st out of 20 stocks

CNMD stock logo

About CONMED Stock (NYSE:CNMD)

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

CNMD Stock Price History

CNMD Stock News Headlines

CONMED (NYSE:CNMD) Reaches New 12-Month Low at $71.25
CONMED (CNMD) Scheduled to Post Earnings on Wednesday
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
CONMED (NYSE:CNMD) Sets New 1-Year Low at $74.19
Should You Invest in CONMED (CNMD)?
3 Retirement Stocks to Buy at a 52-Week Low in March
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
CNMD Apr 2024 120.000 call
CNMD Apr 2024 90.000 put
CONMED Corporation declares $0.20 dividend
CONMED Corporation Announces Quarterly Cash Dividend
CNMD Mar 2024 80.000 call
CNMD Mar 2024 80.000 put
CNMD Mar 2024 105.000 call
CNMD Mar 2024 90.000 put
Cracking The Code: Understanding Analyst Reviews For Conmed
Piper Sandler Reaffirms Their Buy Rating on Conmed (CNMD)
These Analysts Revise Their Forecasts On CONMED After Q4 Results
See More Headlines
Receive CNMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CONMED and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
1/31/2024
Ex-Dividend for 4/5 Dividend
3/14/2024
Dividend Payable
4/05/2024
Today
4/21/2024
Next Earnings (Confirmed)
4/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Employees
4,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$120.43
High Stock Price Target
$141.00
Low Stock Price Target
$98.00
Potential Upside/Downside
+65.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.86
Research Coverage
7 Analysts

Profitability

Net Income
$64.46 million
Pretax Margin
6.49%

Debt

Sales & Book Value

Annual Sales
$1.24 billion
Cash Flow
$6.05 per share
Book Value
$27.13 per share

Miscellaneous

Free Float
28,451,000
Market Cap
$2.24 billion
Optionable
Optionable
Beta
1.33
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

CNMD Stock Analysis - Frequently Asked Questions

Should I buy or sell CONMED stock right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CONMED in the last year. There are currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CNMD shares.
View CNMD analyst ratings
or view top-rated stocks.

What is CONMED's stock price target for 2024?

7 brokers have issued 1 year price targets for CONMED's shares. Their CNMD share price targets range from $98.00 to $141.00. On average, they anticipate the company's stock price to reach $120.43 in the next twelve months. This suggests a possible upside of 65.8% from the stock's current price.
View analysts price targets for CNMD
or view top-rated stocks among Wall Street analysts.

How have CNMD shares performed in 2024?

CONMED's stock was trading at $109.51 at the beginning of the year. Since then, CNMD stock has decreased by 33.7% and is now trading at $72.64.
View the best growth stocks for 2024 here
.

When is CONMED's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 24th 2024.
View our CNMD earnings forecast
.

How can I listen to CONMED's earnings call?

CONMED will be holding an earnings conference call on Wednesday, April 24th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were CONMED's earnings last quarter?

CONMED Co. (NYSE:CNMD) released its quarterly earnings data on Wednesday, January, 31st. The company reported $1.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.11 by $0.05. The company earned $327.05 million during the quarter, compared to analyst estimates of $332.94 million. CONMED had a net margin of 5.18% and a trailing twelve-month return on equity of 13.69%.

How often does CONMED pay dividends? What is the dividend yield for CONMED?

CONMED announced a quarterly dividend on Monday, February 26th. Shareholders of record on Friday, March 15th will be paid a dividend of $0.20 per share on Friday, April 5th. This represents a $0.80 annualized dividend and a dividend yield of 1.10%. The ex-dividend date is Thursday, March 14th.
Read our dividend analysis for CNMD
.

Is CONMED a good dividend stock?

CONMED (NYSE:CNMD) pays an annual dividend of $0.80 per share and currently has a dividend yield of 1.10%. The dividend payout ratio is 39.22%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CNMD will have a dividend payout ratio of 14.11% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CNMD.

What ETFs hold CONMED's stock?
What guidance has CONMED issued on next quarter's earnings?

CONMED updated its FY 2024 earnings guidance on Wednesday, January, 31st. The company provided earnings per share (EPS) guidance of 4.300-4.400 for the period, compared to the consensus earnings per share estimate of 4.400. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion.

Who are CONMED's major shareholders?

CONMED's stock is owned by a variety of institutional and retail investors. Top institutional investors include Mountain Pacific Investment Advisers Inc. ID (0.81%), Portman Square Capital LLP (0.00%), AMI Asset Management Corp (0.18%), State of Alaska Department of Revenue (0.06%), Epiq Partners LLC (0.04%) and Diversified Trust Co (0.04%). Insiders that own company stock include Brian Concannon, Curt R Hartman, Daniel S Jonas, John D Ferrell, Johonna Marie Pelletier, Peter K Shagory, Stanley W Peters III, Todd W Garner and Todd W Garner.
View institutional ownership trends
.

How do I buy shares of CONMED?

Shares of CNMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:CNMD) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners